These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12192102)

  • 1. Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptide.
    Pan W; Solomon B; Maness LM; Kastin AJ
    Exp Biol Med (Maywood); 2002 Sep; 227(8):609-15. PubMed ID: 12192102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier.
    Poduslo JF; Curran GL
    Neuroreport; 2001 Oct; 12(15):3197-200. PubMed ID: 11711855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Pardridge WM
    Bioconjug Chem; 2007; 18(2):447-55. PubMed ID: 17315944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
    Mol Cell Neurosci; 2013 Sep; 56():255-62. PubMed ID: 23831388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.
    Banks WA; Farr SA; Morley JE; Wolf KM; Geylis V; Steinitz M
    Exp Neurol; 2007 Aug; 206(2):248-56. PubMed ID: 17582399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology.
    Vehmas AK; Borchelt DR; Price DL; McCarthy D; Wills-Karp M; Peper MJ; Rudow G; Luyinbazi J; Siew LT; Troncoso JC
    DNA Cell Biol; 2001 Nov; 20(11):713-21. PubMed ID: 11788049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A coiled conformation of amyloid-β recognized by antibody C706.
    Teplyakov A; Obmolova G; Gilliland GL
    Alzheimers Res Ther; 2017 Aug; 9(1):66. PubMed ID: 28830506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice.
    Wang H; Chen F; Du YF; Long Y; Reed MN; Hu M; Suppiramaniam V; Hong H; Tang SS
    Neuropharmacology; 2018 Mar; 131():143-153. PubMed ID: 29248482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.
    Storck SE; Meister S; Nahrath J; Meißner JN; Schubert N; Di Spiezio A; Baches S; Vandenbroucke RE; Bouter Y; Prikulis I; Korth C; Weggen S; Heimann A; Schwaninger M; Bayer TA; Pietrzik CU
    J Clin Invest; 2016 Jan; 126(1):123-36. PubMed ID: 26619118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.
    Saito Y; Buciak J; Yang J; Pardridge WM
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10227-31. PubMed ID: 7479757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.
    Martel CL; Mackic JB; Matsubara E; Governale S; Miguel C; Miao W; McComb JG; Frangione B; Ghiso J; Zlokovic BV
    J Neurochem; 1997 Nov; 69(5):1995-2004. PubMed ID: 9349544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.
    Levites Y; O'Nuallain B; Puligedda RD; Ondrejcak T; Adekar SP; Chen C; Cruz PE; Rosario AM; Macy S; Mably AJ; Walsh DM; Vidal R; Solomon A; Brown D; Rowan MJ; Golde TE; Dessain SK
    J Neurosci; 2015 Apr; 35(16):6265-76. PubMed ID: 25904780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide.
    Dickey CA; Morgan DG; Kudchodkar S; Weiner DB; Bai Y; Cao C; Gordon MN; Ugen KE
    DNA Cell Biol; 2001 Nov; 20(11):723-9. PubMed ID: 11788050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy.
    Mackic JB; Weiss MH; Miao W; Kirkman E; Ghiso J; Calero M; Bading J; Frangione B; Zlokovic BV
    J Neurochem; 1998 Jan; 70(1):210-5. PubMed ID: 9422364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
    Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
    FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.
    Mackic JB; Bading J; Ghiso J; Walker L; Wisniewski T; Frangione B; Zlokovic BV
    Vascul Pharmacol; 2002 Jun; 38(6):303-13. PubMed ID: 12529925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.